Genovese, M. C., Durez, P., Fleischmann, R., Tanaka, Y., Furst, D., Yamanaka, H., . . . Takeuchi, T. (2021). Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies. AVES.
芝加哥风格引文Genovese, Mark C., Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, 与 Tsutomu Takeuchi. Long-term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy in Phase II Studies. AVES, 2021.
MLA引文Genovese, Mark C., et al. Long-term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy in Phase II Studies. AVES, 2021.